Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

Aβ antibodies (eg donanemab, lecanemab)

Source date not recordedAnalyse record ↗

Questionable whether these qualify as general neuro-aging therapeutics vs single disease (AD) specific.

Modality
drug
Availability (US)
by prescription
Biomarkers
MCI, brain imaging, any other dementia diagnostics, APOE4 status
Kind
rejuvenation